Merck Atty's Lies Unravel $200M Patent Win Against Gilead
Merck forfeited its right to enforce two patents covering an ingredient in hepatitis C drugs against rival Gilead due to "numerous unconscionable acts" before and during trial, a California federal judge...To view the full article, register now.
Already a subscriber? Click here to view full article